Earn points on every order · Free shipping on orders over $159 · New products in stock
← Back to Compound Library
Reproductive and Hormonal

HCG

A pregnancy hormone that looks like LH to your body. Men on TRT use it to keep their testicles working and stay fertile.

Research referenceCommunity compiled
Research & reference information

This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.

Overview

A pregnancy hormone that looks like LH to your body.

Men on TRT use it to keep their testicles working and stay fertile.

What It Does

Human Chorionic Gonadotropin, mimics LH to maintain testicular function and testosterone during suppressive cycles.

Binds LH/CG receptors on Leydig cells to stimulate testosterone production.

Reconstitution

Vial SizeBAC Water / SolventConcentration
1000 iu+ 0.5 mL2000 IU/mL
2000 iu+ 1 mL2000 IU/mL
5000 iu+ 2.5 mL2000 IU/mL
10000 iu+ 5 mL2000 IU/mL
Interactive tool

Reconstitution Calculator

Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.

Calculated concentration—Enter both values above.
Optional conversion

Enter a target amount you already have and select the syringe capacity.

Calculated draw—Enter concentration inputs and a target amount.

Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.

Protocol

PhaseFrequencyAmountNotes
StandardMon/Wed/Fri250 IULH-mimetic, maintains testosterone.
HigherMon/Wed/Fri500 IUAt this dose, estrogen (E2) elevation is more likely. Have an AI available and test at Week 4.
FertilityDaily or500–1,000Full fertility support dose. This protocol takes 70+ days to show results in sperm counts.
FDA3×/wk500–1,000FDA Pregnyl/Novarel male-hypogonadism dose (or 4,000 → 2,000 IU 3×/wk). The 250 IU “Standard” above is a lower
labelIU50u
Cycle & Timing

TRT-adjunct: ongoing while on TRT (no scheduled off-cycle). Fertility: 70+ day cycle (one full spermatogenesis cycle). Single-dose ovulation trigger: one IM injection per IVF cycle (per FDA Pregnyl / Novarel labels).

Timing

2–3×/week SubQ, anytime; same days each week.

Population Considerations

Acts like LH, an ovulation trigger and luteal support, timed to the cycle. Men: Mimics LH so the testes make their own testosterone and sperm; low-dose ~250–500 IU every other day keeps intratesticular T and fertility, even on Acts like LH, an ovulation trigger and luteal support, timed to the cycle. Men: Mimics LH so the testes make their own testosterone and sperm; low-dose ~250–500 IU every other day keeps intratesticular T and fertility, even on TRT.

Handling & Stacking

Injection site
SubQ abdomen. Rotate.
Storage
  • Freeze-dried: -4°F.
  • Reconstituted: 36–46°F.
  • Best used within 28 days.
  • No clear reconstituted-potency data (the label lists only an in-use date, not potency), so defer to the 28-day sterility limit.
Side effects
Water retention, mood swings, estrogen elevation.
What to expect
  • Testicular volume maintenance and testosterone support within days.
  • Monitor estrogen, HCG raises both T and E2.
  • Supply math 1000iu → 15 vials | 2000iu → 8 vials | 5000iu → 3 vials | 10000iu → 2 vials (10-wk @ 500 iu × 3/wk)
Pairs well with
CJC-1295 No DAC + Ipamorelin (systemic anabolic environment); Kisspeptin (HPG-axis stimulation)
Avoid
Hormone-sensitive cancer (prostate, breast). Active polycythaemia. Untreated thrombophilia (estradiol elevation)

Safety & Patient Education

Contraindications
Hormone-sensitive malignancy (prostate cancer outside intentional ADT, breast cancer, ovarian cancer) Active thromboembolic disease Untreated thrombophilia Pregnancy (except specific fertility indications under specialist supervision) Polycythemia vera
Warnings
  • Estradiol elevation common; AI may be needed (monitoring mandatory).
  • Thromboembolic risk with elevated E2.
  • OHSS in females can be life-threatening.
  • Mood changes, gynecomastia in males.
  • Precocious puberty in males with cryptorchidism.
Drug interactions
  • AIs (anastrozole, letrozole): manage E2; over-suppression worsens lipids/bone.
  • SERMs (clomiphene, tamoxifen, enclomiphene): redundant HPG overlap.
  • Exogenous testosterone: shuts down LH/FSH, reduces HCG efficacy unless TRT paused/microdosed.
  • Anticoagulants: elevated E2 raises thrombotic risk.
  • Insulin/antidiabetics: monitor glucose at high doses.
Labs
  • E2 (baseline + Wk 4–6); total + free testosterone, LH, FSH, sensitive E2 (baseline/mid/end); SHBG + prolactin baseline; CBC + hematocrit (polycythemia); lipid panel; PSA (men >40); semen analysis baseline + quarterly (fertility); D-dimer if clotting symptoms., Out of range?
  • Low testosterone or high estradiol = the hormone axis needs tuning; hematocrit >54% = blood too thick (donate or hold).
Stop criteria
Hematocrit >54% (donate/hold); E2 persistently above target despite AI; OHSS (distension, weight gain, dyspnea); thrombosis (calf swelling, chest pain, dyspnea, neuro); new breast tenderness/growth.
Patient education
  • Watch for clotting symptoms (leg swelling, calf/chest pain, sudden dyspnea).
  • Estrogen side effects manageable with an AI under physician guidance.
  • Fertility: 70+ days before semen analysis changes.
  • Recon math reflects community TRT-adjunct / PCT use (multi-dose SubQ); FDA labels (Pregnyl, Novarel, Ovidrel) describe single-use IM only; off-label is community-standard but unlabeled.
  • HCG is a licensed biologic (2020 BPCIA), compounding requires a biologics license; US Pregnyl/Novarel supply is intermittent (2026).
References
rxlist · researchdosing · peptidedosages · DailyMed · Coviello 2005